266 related articles for article (PubMed ID: 19449143)
1. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.
Hoffmann O; Zipp F; Weber JR
J Mol Med (Berl); 2009 Aug; 87(8):753-63. PubMed ID: 19449143
[TBL] [Abstract][Full Text] [Related]
2. The role of TRAIL/TRAIL receptors in central nervous system pathology.
Aktas O; Schulze-Topphoff U; Zipp F
Front Biosci; 2007 May; 12():2912-21. PubMed ID: 17485268
[TBL] [Abstract][Full Text] [Related]
3. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.
Huang Y; Erdmann N; Peng H; Zhao Y; Zheng J
Cell Mol Immunol; 2005 Apr; 2(2):113-22. PubMed ID: 16191417
[TBL] [Abstract][Full Text] [Related]
4. Clinical perspectives of TRAIL: insights into central nervous system disorders.
Tisato V; Gonelli A; Voltan R; Secchiero P; Zauli G
Cell Mol Life Sci; 2016 May; 73(10):2017-27. PubMed ID: 26910728
[TBL] [Abstract][Full Text] [Related]
5. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
Front Immunol; 2018; 9():15. PubMed ID: 29403497
[TBL] [Abstract][Full Text] [Related]
6. TRAIL induces death of human oligodendrocytes isolated from adult brain.
Matysiak M; Jurewicz A; Jaskolski D; Selmaj K
Brain; 2002 Nov; 125(Pt 11):2469-80. PubMed ID: 12390973
[TBL] [Abstract][Full Text] [Related]
7. TRAIL limits excessive host immune responses in bacterial meningitis.
Hoffmann O; Priller J; Prozorovski T; Schulze-Topphoff U; Baeva N; Lunemann JD; Aktas O; Mahrhofer C; Stricker S; Zipp F; Weber JR
J Clin Invest; 2007 Jul; 117(7):2004-13. PubMed ID: 17571163
[TBL] [Abstract][Full Text] [Related]
8. The immune system on the TRAIL of Alzheimer's disease.
Burgaletto C; Munafò A; Di Benedetto G; De Francisci C; Caraci F; Di Mauro R; Bucolo C; Bernardini R; Cantarella G
J Neuroinflammation; 2020 Oct; 17(1):298. PubMed ID: 33050925
[TBL] [Abstract][Full Text] [Related]
9. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
10. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
[TBL] [Abstract][Full Text] [Related]
11. Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
Aktas O; Smorodchenko A; Brocke S; Infante-Duarte C; Schulze Topphoff U; Vogt J; Prozorovski T; Meier S; Osmanova V; Pohl E; Bechmann I; Nitsch R; Zipp F
Neuron; 2005 May; 46(3):421-32. PubMed ID: 15882642
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses.
Collison A; Foster PS; Mattes J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1049-53. PubMed ID: 19656161
[TBL] [Abstract][Full Text] [Related]
13. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.
Wendling U; Walczak H; Dörr J; Jaboci C; Weller M; Krammer PH; Zipp F
Cell Death Differ; 2000 Jul; 7(7):637-44. PubMed ID: 10889508
[TBL] [Abstract][Full Text] [Related]
14. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
15. Theiler's murine encephalomyelitis virus induces apoptosis in gamma interferon-activated M1 differentiated myelomonocytic cells through a mechanism involving tumor necrosis factor alpha (TNF-alpha) and TNF-alpha-related apoptosis-inducing ligand.
Jelachich ML; Lipton HL
J Virol; 2001 Jul; 75(13):5930-8. PubMed ID: 11390594
[TBL] [Abstract][Full Text] [Related]
16. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
Cretney E; McQualter JL; Kayagaki N; Yagita H; Bernard CC; Grewal IS; Ashkenazi A; Smyth MJ
Immunol Cell Biol; 2005 Oct; 83(5):511-9. PubMed ID: 16174101
[TBL] [Abstract][Full Text] [Related]
17. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
[TBL] [Abstract][Full Text] [Related]
18. Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain.
Dörr J; Bechmann I; Waiczies S; Aktas O; Walczak H; Krammer PH; Nitsch R; Zipp F
J Neurosci; 2002 Feb; 22(4):RC209. PubMed ID: 11844843
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
20. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis.
Chyuan IT; Tsai HF; Liao HJ; Wu CS; Hsu PN
Cell Mol Immunol; 2018 Sep; 15(9):846-857. PubMed ID: 28392572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
